What are your ongoing GDPR data requirements when closing a clinical trial?
As with all aspects of GDPR compliance, any system, process or infrastructure that uses personal data must be created and designed from the beginning by identifying possible risks to the rights and freedoms of the data subjects and minimising them before they can cause actual damage – privacy by design. GDPR data requirements on closing a clinical trial are no exception.
The EEA and UK continue to pack a punch in the clinical trial arena – but what does this mean for sponsors from a data protection perspective?
Choosing the right country or countries, sites and investigators for a clinical trial is critical for success in any pharmaceutical drug or medical device development programme.